KACTUS has developed a series of high-activity enzyme for in vitro synthesis of DNA vectors, based on their SAMS™ technology platform.
KACTUS: DNA Synthesis Enzymes

KACTUS has developed a series of high-activity enzyme for in vitro synthesis of DNA vectors, based on their SAMS™ technology platform.
KACTUS have used their SAMS™ protein production platform to develop high-quality enzymes for in vitro synthesis of mRNA (GMP-Grade & GMP-Ready).
KACTUS has developed a GMP-grade universal nuclease – MaxNuclease™, which degrades all DNA and RNA into 2-5 base oligonucleotides.
At KACTUS, they have developed a highly-active, wild-type Cas9 nuclease based on their SAMS™ technology platform.
AccuBase® is a cytosine base editor that converts a C-G base pair into a T-A base pair in the genome. Designed by Base Therapeutics, manufactured by KACTUS.
All the analytical tools you need for your research: in vivo products, tetramers, ELISAs, small molecules & proteins (RUO & GMP)!